Jaundice epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:


* Cholestatic jaundice mainly from liver cancer, hepatitis, and liver cirrhosis commonly affects older patients.<ref name="urlAge and gender analysis of jaundice patients | Yu | The Journal of Bioscience and Medicine" />
* Cholestatic jaundice mainly from liver cancer, hepatitis, and liver cirrhosis commonly affects older patients.<ref name="urlAge and gender analysis of jaundice patients | Yu | The Journal of Bioscience and Medicine" />
** Cirrhosis is infrequently seen in young adults.
** The incidence of cirrhosis increases with age; the median age at diagnosis of cirrhosis due to [[alcoholic liver disease]] is 52 years.


=== Gender ===
=== Gender ===

Revision as of 14:59, 7 February 2018

Jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Jaundice epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Jaundice epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Jaundice epidemiology and demographics

CDC on Jaundice epidemiology and demographics

Jaundice epidemiology and demographics in the news

Blogs on Jaundice epidemiology and demographics

Directions to Hospitals Treating Jaundice

Risk calculators and risk factors for Jaundice epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of jaundice is approximately 40,000 per 100,000 individuals of intensive care unit patients.[1]

Race

  • Neonatal jaundice is more common among Asian and mixed Asian/white infants than white infants.[2].
  • The prevalence of cirrhosis is higher in:[3]
    • Non-Hispanic blacks
    • Mexican Americans
    • Hispanics with hepatitis C infection

Age

  • Hepatocellular jaundice mainly from viral hepatitis commonly affects young patients.[4]
  • Cholestatic jaundice mainly from liver cancer, hepatitis, and liver cirrhosis commonly affects older patients.[4]
    • Cirrhosis is infrequently seen in young adults.
    • The incidence of cirrhosis increases with age; the median age at diagnosis of cirrhosis due to alcoholic liver disease is 52 years.

Gender

  • Male are more commonly affected by hepatocellular jaundice and liver cancer than female.[4]
  •  Female are more commonly affected by hemolytic jaundice mainly from cholangiocarcinoma than male.[4]

References

  1. Bansal V, Schuchert VD (2006). "Jaundice in the intensive care unit". Surg. Clin. North Am. 86 (6): 1495–502. doi:10.1016/j.suc.2006.09.007. PMID 17116459.
  2. Setia S, Villaveces A, Dhillon P, Mueller BA (2002). "Neonatal jaundice in Asian, white, and mixed-race infants". Arch Pediatr Adolesc Med. 156 (3): 276–9. PMID 11876673.
  3. Adams LA, Sanderson S, Lindor KD, Angulo P (2005). "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies". J. Hepatol. 42 (1): 132–8. doi:10.1016/j.jhep.2004.09.012. PMID 15629518.
  4. 4.0 4.1 4.2 4.3 "Age and gender analysis of jaundice patients | Yu | The Journal of Bioscience and Medicine".


Template:WH Template:WS